Allergan plc Ordinary Shares (AGN) was Reiterated by RBC Capital Mkts to “Outperform” while Lowering the Price Target of the company shares to $ 300 from a previous price target of $307 . RBC Capital Mkts advised their investors in a research report released on Aug 9, 2016.
Many Wall Street Analysts have commented on Allergan plc Ordinary Shares. Shares were Reiterated by Deutsche Bank on Aug 9, 2016 to “Buy” and Lowered the Price Target to $ 278 from a previous price target of $282 .Company shares were Reiterated by Mizuho on Aug 5, 2016 to “Neutral”, Firm has raised the Price Target to $ 246 from a previous price target of $232 .Company shares were Reiterated by Leerink Partners on Jul 27, 2016 to “Outperform”, Firm has raised the Price Target to $ 294 from a previous price target of $272 .
On the company’s financial health, Allergan plc Ordinary Shares reported $3.35 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $3.32. The company had revenue of $3709.00 million for the quarter, compared to analysts expectations of $3977.46 million. The company’s revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.41 EPS.
Allergan plc Ordinary Shares closed down -5.54 points or -2.18% at $248.31 with 66,91,438 shares getting traded on Monday. Post opening the session at $249.25, the shares hit an intraday low of $242.24 and an intraday high of $251.17 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
In a different news, on Jun 6, 2016, Maria Teresa Hilado (CFO) purchased 661 shares at $241.57 per share price. According to the SEC, on May 12, 2016, Nesli Basgoz (director) sold 459 shares at $225.10 per share price. On Aug 24, 2015, Brent L Saunders (CEO) purchased 1,000 shares at $301.94 per share price, according to the Form-4 filing with the securities and exchange commission.